Advertisement
EW vs SIBN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EW is a StrongBuy and SIBN is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EW’s FA Score shows that 2 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).
- EW’s FA Score: 2 green, 3 red.
- SIBN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EW’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 4 bullish TA indicator(s).
- EW’s TA Score: 5 bullish, 5 bearish.
- SIBN’s TA Score: 4 bullish, 2 bearish.
Price Growth
EW (@Medical/Nursing Services) experienced а -0.46% price change this week, while SIBN (@Medical/Nursing Services) price change was +4.63% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.22%. For the same industry, the average monthly price growth was -3.84%, and the average quarterly price growth was -16.30%.
Reported Earning Dates
EW is expected to report earnings on Jul 23, 2026.
SIBN is expected to report earnings on Aug 10, 2026.
Industries' Descriptions
@Medical/Nursing Services (-0.22% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| EW | SIBN | EW / SIBN | |
| Capitalization | 49.4B | 702M | 7,037% |
| EBITDA | 1.56B | -8.03M | -19,417% |
| Gain YTD | 0.739 | -19.777 | -4% |
| P/E Ratio | 46.42 | N/A | - |
| Revenue | 6.3B | 206M | 3,060% |
| Total Cash | 3.67B | 145M | 2,532% |
| Total Debt | 703M | 42.9M | 1,639% |
EW | SIBN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 66 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 69 | 95 | |
PRICE GROWTH RATING 1..100 | 33 | 51 | |
P/E GROWTH RATING 1..100 | 20 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 21 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIBN's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for EW (81). This means that SIBN’s stock grew somewhat faster than EW’s over the last 12 months.
SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EW (100). This means that SIBN’s stock grew similarly to EW’s over the last 12 months.
EW's SMR Rating (69) in the Medical Specialties industry is in the same range as SIBN (95). This means that EW’s stock grew similarly to SIBN’s over the last 12 months.
EW's Price Growth Rating (33) in the Medical Specialties industry is in the same range as SIBN (51). This means that EW’s stock grew similarly to SIBN’s over the last 12 months.
EW's P/E Growth Rating (20) in the Medical Specialties industry is significantly better than the same rating for SIBN (100). This means that EW’s stock grew significantly faster than SIBN’s over the last 12 months.
| EW | SIBN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 77% | N/A |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 75% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 77% |
| Advances ODDS (%) | 8 days ago 59% | 19 days ago 74% |
| Declines ODDS (%) | 12 days ago 59% | 13 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 62% | N/A |
| Aroon ODDS (%) | 2 days ago 47% | 2 days ago 66% |
Advertisement
EW and
Correlation & Price change
A.I.dvisor indicates that over the last year, EW has been loosely correlated with ISRG. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if EW jumps, then ISRG could also see price increases.
SIBN and
Correlation & Price change
A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To SIBN | 1D Price Change % | ||
|---|---|---|---|---|
| SIBN | 100% | -0.13% | ||
| ATEC - SIBN | 45% Loosely correlated | -2.95% | ||
| ATRC - SIBN | 40% Loosely correlated | -1.22% | ||
| QDEL - SIBN | 40% Loosely correlated | -9.51% | ||
| PODD - SIBN | 40% Loosely correlated | -4.66% | ||
| EW - SIBN | 40% Loosely correlated | -1.69% | ||
More | ||||